After a long, cash-strapped journey, French biotech Abivax has presented top-line data from the twin phase 3 trials of its lead ulcerative colitis candidate.  | After a long, cash-strapped journey, ...

An experimental oral treatment from Abivax helped ease symptoms in patients with ulcerative colitis, a major win for the ...